Cargando…

Incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes

BACKGROUND: Diabetes has strongly been linked to atrial fibrillation, ischaemic heart disease and heart failure. The epidemiology of these cardiovascular diseases is changing, however, due to changes in prevalence of obesity-related conditions and preventive measures. Recent population studies on in...

Descripción completa

Detalles Bibliográficos
Autores principales: Groenewegen, Amy, Zwartkruis, Victor W., Cekic, Betül, de Boer, Rudolf. A., Rienstra, Michiel, Hoes, Arno W., Rutten, Frans H., Hollander, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210360/
https://www.ncbi.nlm.nih.gov/pubmed/34134731
http://dx.doi.org/10.1186/s12933-021-01313-7
_version_ 1783709294939602944
author Groenewegen, Amy
Zwartkruis, Victor W.
Cekic, Betül
de Boer, Rudolf. A.
Rienstra, Michiel
Hoes, Arno W.
Rutten, Frans H.
Hollander, Monika
author_facet Groenewegen, Amy
Zwartkruis, Victor W.
Cekic, Betül
de Boer, Rudolf. A.
Rienstra, Michiel
Hoes, Arno W.
Rutten, Frans H.
Hollander, Monika
author_sort Groenewegen, Amy
collection PubMed
description BACKGROUND: Diabetes has strongly been linked to atrial fibrillation, ischaemic heart disease and heart failure. The epidemiology of these cardiovascular diseases is changing, however, due to changes in prevalence of obesity-related conditions and preventive measures. Recent population studies on incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes are needed. METHODS: A dynamic longitudinal cohort study was performed using primary care databases of the Julius General Practitioners’ Network. Diabetes status was determined at baseline (1 January 2014 or upon entering the cohort) and participants were followed-up for atrial fibrillation, ischaemic heart disease and heart failure until 1 February 2019. Age and sex-specific incidence and incidence rate ratios were calculated. RESULTS: Mean follow-up was 4.2 years, 12,168 patients were included in the diabetes group, and 130,143 individuals in the background group. Incidence rate ratios, adjusted for age and sex, were 1.17 (95% confidence interval 1.06–1.30) for atrial fibrillation, 1.66 (1.55–1.83) for ischaemic heart disease, and 2.36 (2.10–2.64) for heart failure. Overall, incidence rate ratios were highest in the younger age categories, converging thereafter. CONCLUSION: There is a clear association between diabetes and incidence of the major chronic progressive heart diseases, notably with heart failure with a more than twice increased risk. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-021-01313-7.
format Online
Article
Text
id pubmed-8210360
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82103602021-06-17 Incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes Groenewegen, Amy Zwartkruis, Victor W. Cekic, Betül de Boer, Rudolf. A. Rienstra, Michiel Hoes, Arno W. Rutten, Frans H. Hollander, Monika Cardiovasc Diabetol Original Investigation BACKGROUND: Diabetes has strongly been linked to atrial fibrillation, ischaemic heart disease and heart failure. The epidemiology of these cardiovascular diseases is changing, however, due to changes in prevalence of obesity-related conditions and preventive measures. Recent population studies on incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes are needed. METHODS: A dynamic longitudinal cohort study was performed using primary care databases of the Julius General Practitioners’ Network. Diabetes status was determined at baseline (1 January 2014 or upon entering the cohort) and participants were followed-up for atrial fibrillation, ischaemic heart disease and heart failure until 1 February 2019. Age and sex-specific incidence and incidence rate ratios were calculated. RESULTS: Mean follow-up was 4.2 years, 12,168 patients were included in the diabetes group, and 130,143 individuals in the background group. Incidence rate ratios, adjusted for age and sex, were 1.17 (95% confidence interval 1.06–1.30) for atrial fibrillation, 1.66 (1.55–1.83) for ischaemic heart disease, and 2.36 (2.10–2.64) for heart failure. Overall, incidence rate ratios were highest in the younger age categories, converging thereafter. CONCLUSION: There is a clear association between diabetes and incidence of the major chronic progressive heart diseases, notably with heart failure with a more than twice increased risk. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-021-01313-7. BioMed Central 2021-06-16 /pmc/articles/PMC8210360/ /pubmed/34134731 http://dx.doi.org/10.1186/s12933-021-01313-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Original Investigation
Groenewegen, Amy
Zwartkruis, Victor W.
Cekic, Betül
de Boer, Rudolf. A.
Rienstra, Michiel
Hoes, Arno W.
Rutten, Frans H.
Hollander, Monika
Incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes
title Incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes
title_full Incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes
title_fullStr Incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes
title_full_unstemmed Incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes
title_short Incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes
title_sort incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210360/
https://www.ncbi.nlm.nih.gov/pubmed/34134731
http://dx.doi.org/10.1186/s12933-021-01313-7
work_keys_str_mv AT groenewegenamy incidenceofatrialfibrillationischaemicheartdiseaseandheartfailureinpatientswithdiabetes
AT zwartkruisvictorw incidenceofatrialfibrillationischaemicheartdiseaseandheartfailureinpatientswithdiabetes
AT cekicbetul incidenceofatrialfibrillationischaemicheartdiseaseandheartfailureinpatientswithdiabetes
AT deboerrudolfa incidenceofatrialfibrillationischaemicheartdiseaseandheartfailureinpatientswithdiabetes
AT rienstramichiel incidenceofatrialfibrillationischaemicheartdiseaseandheartfailureinpatientswithdiabetes
AT hoesarnow incidenceofatrialfibrillationischaemicheartdiseaseandheartfailureinpatientswithdiabetes
AT ruttenfransh incidenceofatrialfibrillationischaemicheartdiseaseandheartfailureinpatientswithdiabetes
AT hollandermonika incidenceofatrialfibrillationischaemicheartdiseaseandheartfailureinpatientswithdiabetes